These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 7865648)
1. Effects of pantoprazole on endocrine function in healthy male volunteers. Dammann HG; Bethke T; Burkhardt F; Wolf N; Khalil H; Luehmann R Aliment Pharmacol Ther; 1994 Oct; 8(5):549-54. PubMed ID: 7865648 [TBL] [Abstract][Full Text] [Related]
2. The effects of oral rabeprazole on endocrine and gastric secretory function in healthy volunteers. Dammann HG; Burkhardt F; Wolf N Aliment Pharmacol Ther; 1999 Sep; 13(9):1195-203. PubMed ID: 10468701 [TBL] [Abstract][Full Text] [Related]
3. Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion. Dammann HG; Burkhardt F Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1277-82. PubMed ID: 10563540 [TBL] [Abstract][Full Text] [Related]
4. Twenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole. Hartmann M; Theiss U; Huber R; Lühmann R; Bliesath H; Wurst W; Lücker PW Aliment Pharmacol Ther; 1996 Jun; 10(3):359-66. PubMed ID: 8791964 [TBL] [Abstract][Full Text] [Related]
5. Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers. Tutuian R; Katz PO; Bochenek W; Castell DO Aliment Pharmacol Ther; 2002 Apr; 16(4):829-36. PubMed ID: 11929403 [TBL] [Abstract][Full Text] [Related]
6. Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs. Bersenas AM; Mathews KA; Allen DG; Conlon PD Am J Vet Res; 2005 Mar; 66(3):425-31. PubMed ID: 15822586 [TBL] [Abstract][Full Text] [Related]
7. Survival of the probiotic, L. plantarum 299v and its effects on the faecal bacterial flora, with and without gastric acid inhibition. Goossens D; Jonkers D; Russel M; Thijs A; van den Bogaard A; Stobberingh E; Stockbrügger R Dig Liver Dis; 2005 Jan; 37(1):44-50. PubMed ID: 15702859 [TBL] [Abstract][Full Text] [Related]
8. Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole. Hartmann M; Ehrlich A; Fuder H; Lühmann R; Emeklibas S; Timmer W; Wurst W; Lücker PW Aliment Pharmacol Ther; 1998 Oct; 12(10):1027-32. PubMed ID: 9798809 [TBL] [Abstract][Full Text] [Related]
9. Twenty-four-hour monitoring of intragastric acidity: comparison between lansoprazole 30mg and pantoprazole 40mg. Florent C; Forestier S Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):195-200. PubMed ID: 9058634 [TBL] [Abstract][Full Text] [Related]
10. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man. Hartmann M; Huber R; Bliesath H; Steinijans VW; Koch HJ; Wurst W; Kunz K Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S67-71. PubMed ID: 8793605 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults. Pratha VS; Hogan DL; Lane JR; Williams PJ; Burton MS; Lynn RB; Karlstadt RG Dig Dis Sci; 2006 Jan; 51(1):123-31. PubMed ID: 16416224 [TBL] [Abstract][Full Text] [Related]
12. Effect of pantoprazole on 24-h intragastric pH and serum gastrin in humans. Londong W Aliment Pharmacol Ther; 1994; 8 Suppl 1():39-46. PubMed ID: 8180293 [TBL] [Abstract][Full Text] [Related]
13. Lack of influence of pantoprazole on the disposition kinetics of theophylline in man. Schulz HU; Hartmann M; Steinijans VW; Huber R; Lührmann B; Bliesath H; Wurst W Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S51-7. PubMed ID: 8793603 [TBL] [Abstract][Full Text] [Related]
14. Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously. Freston J; Chiu YL; Pan WJ; Lukasik N; Täubel J Am J Gastroenterol; 2001 Jul; 96(7):2058-65. PubMed ID: 11467632 [TBL] [Abstract][Full Text] [Related]
15. Effects of oral pantoprazole on 24-hour intragastric acidity and plasma gastrin profiles. Hannan A; Weil J; Broom C; Walt RP Aliment Pharmacol Ther; 1992 Jun; 6(3):373-80. PubMed ID: 1600053 [TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic effects of 3-day intravenous treatment with pantoprazole or ranitidine after 10 days of oral ranitidine. Ley LM; Becker A; Lühmann R; Sander P; Lücker PW Methods Find Exp Clin Pharmacol; 2005; 27(1):25-9. PubMed ID: 15834456 [TBL] [Abstract][Full Text] [Related]
17. No influence of pantoprazole on the pharmacokinetics of phenytoin. Middle MV; Müller FO; Schall R; Groenewoud G; Hundt HK; Huber R; Bliesath H; Steinijans VW Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S72-5. PubMed ID: 8793606 [TBL] [Abstract][Full Text] [Related]
18. [Acid-supressing capacity of omeprazole 20 mg tablets vs pantoprazole 20 and 40 mg tablets. A pilot study in volunteers]. Corti R; Améndola R; Menéndez G; Diwecj J; Schenone L; Soutric J; Caruso N Acta Gastroenterol Latinoam; 2003; 33(4):199-203. PubMed ID: 14708472 [TBL] [Abstract][Full Text] [Related]
19. Intragastric acidity after switching from 5-day treatment with intravenous pantoprazole 40 mg/d to 5-day treatment with oral esomeprazole 40 mg/d or pantoprazole 40 mg/d: an open-label crossover study in healthy adult volunteers. Miner PB; Tutuian R; Castell DO; Liu S; Sostek MB Clin Ther; 2006 May; 28(5):725-33. PubMed ID: 16861094 [TBL] [Abstract][Full Text] [Related]
20. The effect of intravenous pantoprazole and ranitidine for improving preoperative gastric fluid properties in adults undergoing elective surgery. Memiş D; Turan A; Karamanlioglu B; Saral P; Türe M; Pamukçu Z Anesth Analg; 2003 Nov; 97(5):1360-1363. PubMed ID: 14570652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]